Inhibition of NF-κB-Mediated Proinflammatory Transcription by Ru(II) Complexes of Anti-Angiogenic Ligands in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Inhibition of NF-κB-Mediated Proinflammatory Transcription by Ru(II) Complexes of Anti-Angiogenic Ligands in Triple-Negative Breast Cancer

Published:2024-03-23 Issue:7 Volume:67 Page:5902-5923
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chakraborty Ayan¹,Ghosh Shilpendu¹^ORCID,Chakraborty Manas Pratim²,Mukherjee Sujato¹^ORCID,Roy Shantanu Saha³,Das Rahul²^ORCID,Acharya Moulinath³,Mukherjee Arindam¹^ORCID

Affiliation:

1. Department of Chemical Sciences and Centre for Advanced Functional Materials (CAFM), Indian Institute of Science Education and Research Kolkata, Mohanpur Campus, Mohanpur 741246, India

2. Department of Biological Sciences and Centre for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur Campus, Mohanpur 741246, India

3. National Institute of Biomedical Genomics, Kalyani 741251, India

Funder

Council of Scientific and Industrial Research, India

University Grants Commission

Science and Engineering Research Board

Indian Institute of Science Education and Research Kolkata

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00169

Reference88 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Breast cancer in India: Present scenario and the challenges ahead

3. Triple‑negative breast cancer therapy: Current and future perspectives (Review)

4. Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

5. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024